Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis

J Neuroimmunol. 2022 Jun 15:367:577849. doi: 10.1016/j.jneuroim.2022.577849. Epub 2022 Mar 26.

Abstract

Methods: Cerebrospinal fluid (CSF) and plasma levels of 38 biomarkers from 20 neurosarcoidosis (NS) patients were compared to healthy controls (HC).

Results: In CSF, 25 biomarkers were significantly elevated compared to HC: IFNγ, TNFα, TNFβ, IL-2, IL-6, IL-10, IL-12B, IL-15, IL-16, CCL2, CCL3, CCL4, CCL11, CCL13, CCL17, CCL22, CCL26, CXCL8, CXCL10, TNFR2, VEGF-A, PIGF, SAA, VCAM1, and ICAM1. In plasma, 12 biomarkers were significantly elevated compared to HC: IFNγ, TNFα, CCL2, CCL3, CCL4, CCL17, CXCL10, VEGFR1, PIGF, SAA, VCAM1, and ICAM1.

Conclusion: NS patients have profoundly elevated cytokines, chemokines, vascular angiogenesis, and vascular injury biomarkers in CSF and plasma.

Keywords: Biomarkers; Chemokines; Cytokines; Neurosarcoidosis; Vascular angiogenesis; Vascular injury.

MeSH terms

  • Biomarkers
  • Central Nervous System Diseases* / blood
  • Central Nervous System Diseases* / cerebrospinal fluid
  • Chemokines*
  • Cytokines*
  • Humans
  • Sarcoidosis* / blood
  • Sarcoidosis* / cerebrospinal fluid

Substances

  • Biomarkers
  • Chemokines
  • Cytokines

Supplementary concepts

  • Neurosarcoidosis